T
Tetsuya Kimura
Researcher at Daiichi Sankyo
Publications - 3
Citations - 328
Tetsuya Kimura is an academic researcher from Daiichi Sankyo. The author has contributed to research in topics: Warfarin & Edoxaban. The author has an hindex of 3, co-authored 3 publications receiving 270 citations.
Papers
More filters
Journal ArticleDOI
Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial
Eri Toda Kato,Robert P. Giugliano,Christian T. Ruff,Yukihiro Koretsune,Takeshi Yamashita,Róbert Gábor Kiss,Francesco Nordio,Sabina A. Murphy,Tetsuya Kimura,James Jin,Hans Lanz,Michele Mercuri,Eugene Braunwald,Elliott M. Antman +13 more
TL;DR: Age has a greater influence on major bleeding than thromboembolic risk in patients with atrial fibrillation, and treatment of elderly patients with edoxaban provides an even greater absolute reduction in safety events over warfarin, compared to treatment with Edoxaban versus warFarin in younger patients.
Journal ArticleDOI
Edoxaban vs. Warfarin in East Asian Patients With Atrial Fibrillation - An ENGAGE AF-TIMI 48 Subanalysis.
Takeshi Yamashita,Yukihiro Koretsune,Yuejin Yang,Shih Ann Chen,Namsik Chung,Yuichi J. Shimada,Tetsuya Kimura,Koichi Miyazaki,Kenji Abe,Michele Mercuri,Christian T. Ruff,Robert P. Giugliano +11 more
TL;DR: Once-daily edoxaban provided similar efficacy to warfarin while reducing major bleeding risk in the East Asian population.
Journal ArticleDOI
Effects of Regional Differences in Asia on Efficacy and Safety of Edoxaban Compared With Warfarin – Insights From the ENGAGE AF-TIMI 48 Trial –
Yuichi J. Shimada,Takeshi Yamashita,Yukihiro Koretsune,Tetsuya Kimura,Kenji Abe,Shunichi Sasaki,Michele Mercuri,Christian T. Ruff,Robert P. Giugliano +8 more
TL;DR: HEDE had a greater relative efficacy and safety in EA compared with Japan that was only partially explained by differences in baseline characteristics and TTR.